HeartSciences HSCS
NASDAQ HSCS
$4.36 +0.31 (+7.77%)
As of: Sep 30, 2026 · 1:13 PM EDT

HeartSciences Inc. (HSCS) EBITDA Margin (2021 - 2026)

Updated

HeartSciences' EBITDA Margin came in at -139655.14% for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 41391.56 percentage points from -98263.58% a year earlier.

Analysis

HeartSciences Inc. (HSCS) EBITDA Margin (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jul 31, 2026, HeartSciences reported EBITDA Margin of -146374.98%, down 16484.15 percentage points year-over-year; for FY2026 (ended Apr 30, 2026), it was -194143.92%, down 2995.14 percentage points from FY2025.

  • EBITDA Margin carries a four-year change of -161563.16 percentage points (FY2022 to FY2026).
  • Going back by fiscal year, EBITDA Margin was -191148.78% in FY2025 (-157396.75 pp), -33752.03% in FY2024 (+84423.68 pp), -118175.71% in FY2023 (-85594.95 pp) and -32580.76% in FY2022.
  • The fiscal Q1 2027 figure represents the lowest quarterly EBITDA Margin in data going back to fiscal Q1 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 -139,655.14%
Oct 31, 2025 -85,423.60%
Jul 31, 2025 -98,263.58%
Apr 30, 2025 -43,974.39%
Jan 31, 2024 -10,351.46%
Oct 31, 2023 -40,059.15%
Jan 31, 2023 -66,791.69%
Jul 31, 2022 -44,490.16%
Apr 30, 2022 -47,512.99%
Jan 31, 2022 -39,919.38%
Jul 31, 2021 -8,918.67%
API Access

HeartSciences Inc. EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HSCS&period=max&api_key=YOUR_API_KEY